0001209191-16-138312.txt : 20160823 0001209191-16-138312.hdr.sgml : 20160823 20160823162944 ACCESSION NUMBER: 0001209191-16-138312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160822 FILED AS OF DATE: 20160823 DATE AS OF CHANGE: 20160823 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASEY MICHAEL D CENTRAL INDEX KEY: 0001190435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 161847480 MAIL ADDRESS: STREET 1: ALLOS THERAPEUTICS, INC. STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-22 0 0000816284 CELGENE CORP /DE/ CELG 0001190435 CASEY MICHAEL D C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 1 0 0 0 Common Stock 2016-08-22 4 S 0 43134 114.01 D 85485 I Family Trust The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $113.72 to $114.22, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ Mark J. Alles ________________________________________________ Mark J. Alles, Attorney-in-Fact 2016-08-23